BioMedNewsBreaks – ROTH MKM’s Upcoming Conference to Feature Public Healthcare Companies Across Multiple Sub-Sectors

October 9, 2023 11:34:58

ROTH MKM, a full-service investment bank focused on serving growth companies and their investors, today announced plans to host its 2023 Healthcare Opportunities Conference in New York City on Oct. 12, 2023. The event will provide pre-qualified institutional investors and healthcare industry professionals the opportunity to interact closely with C-level executives of approximately 25 public companies selected by ROTH’s research analysts. With a multiple sub-sector focus, the conference will feature participating companies operating in biotechnology, pharmaceuticals, medical technologies and oncology therapeutics. “Meaningful conversations between companies and a wide spectrum of investors will be the main focus of our Healthcare Opportunities Conference,” said James Antonopoulos, managing director, head of healthcare investment banking at ROTH. “As part of fostering new relationships and deepening existing ones, institutional investors will benefit from company presentations, insights and operational updates from the select small and micro-cap companies showcased during this event. At ROTH, we maintain a strong position as one of the leaders in capital formation and advisory services for growth-oriented healthcare companies. This conference represents some of the most promising and exciting areas in the healthcare industry today.”

To view the full press release, visit


ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Its full-service platform provides capital raising, high impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately held, employee-owned organization and maintains offices throughout the U.S. For more information on ROTH MKM, visit

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

San Francisco, CA
415.949.5050 Office

BioMedWire is powered by IBN